Denali Therapeutics Inc. (DNLI) SEC filings
DNLI SEC filings moved a median of +1.20% by the close. DNLI SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the DNLI overview →
62 measured DNLI SEC filing events.
Where these DNLI SEC filings landedvs 60 measured DNLI SEC filing reactions
| Middle 50% of DNLI SEC filing reactions | -2.11% to +4.45% |
|---|---|
| Median reaction (to close) | +1.20% |
| Measured reactions | 60 |
Point-in-time · zero look-ahead
Half of the 60 DNLI SEC filing events with a measured close landed between -2.11% and +4.45%; 60% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Denali Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.63% | -2.51% | |
| Form 8-K Denali Therapeutics Inc. For: Aug 06 | SEC filing · Form 8-K | -0.63% | -2.51% | |
| Form 8-K Denali Therapeutics Inc. For: Jul 27 | SEC filing · Form 8-K | -0.42% | +0.54% | |
| Form 8-K Denali Therapeutics Inc. For: Jun 12 | SEC filing · Form 8-K | +0.14% | -3.80% | |
| Form 8-K Denali Therapeutics Inc. For: Jun 03 | SEC filing · Form 8-K | +0.35% | +2.23% | |
| Form 8-K Denali Therapeutics Inc. For: May 21 | SEC filing · Form 8-K | -0.82% | -1.32% | |
| Form 10-Q Denali Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.29% | +0.93% | |
| Form 8-K Denali Therapeutics Inc. For: May 07 | SEC filing · Form 8-K | +2.29% | +0.93% | |
| Form ARS Denali Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | +0.84% | -0.15% | |
| Form DEF 14A Denali Therapeutics Inc. For: Dec 31 | SEC filing · Form DEF | +0.84% | -0.15% | |
| Form DEFA14A Denali Therapeutics Inc. | SEC filing · Form DEFA14A | +0.84% | -0.15% | |
| Form 8-K Denali Therapeutics Inc. For: Apr 03 | SEC filing · Form 8-K | -0.78% | -5.92% | |
| Form 8-K Denali Therapeutics Inc. For: Mar 27 | SEC filing · Form 8-K | -0.05% | +1.59% | |
| Form 8-K Denali Therapeutics Inc. For: Mar 25 | SEC filing · Form 8-K | +0.41% | +1.49% | |
| Form 10-K Denali Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -2.59% | +1.44% | |
| Form 8-K Denali Therapeutics Inc. For: Feb 26 | SEC filing · Form 8-K | -2.59% | +1.44% | |
| Form S-8 Denali Therapeutics Inc. | SEC filing · Form S-8 | -2.59% | +1.44% | |
| Form 8-K Denali Therapeutics Inc. For: Jan 06 | SEC filing · Form 8-K | -0.37% | +6.70% | |
| Form 8-K Denali Therapeutics Inc. For: Dec 09 | SEC filing · Form 8-K | +1.32% | +0.00% | |
| Form 8-K Denali Therapeutics Inc. For: Dec 04 | SEC filing · Form 8-K | -0.08% | +7.14% | |
| Form 10-Q Denali Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.19% | +5.26% | |
| Form 8-K Denali Therapeutics Inc. For: Nov 06 | SEC filing · Form 8-K | +1.19% | +5.26% | |
| Form 8-K Denali Therapeutics Inc. For: Oct 13 | SEC filing · Form 8-K | -0.90% | +5.04% | |
| Form 10-Q Denali Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.64% | — | |
| Form 8-K Denali Therapeutics Inc. For: Aug 11 | SEC filing · Form 8-K | -1.64% | — | |
| Form 8-K Denali Therapeutics Inc. For: Jul 07 | SEC filing · Form 8-K | -2.21% | -1.72% | |
| Form 8-K Denali Therapeutics Inc. For: Jun 03 | SEC filing · Form 8-K | +1.29% | +3.29% | |
| Form 10-Q Denali Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.25% | +2.65% | |
| Form 8-K Denali Therapeutics Inc. For: May 06 | SEC filing · Form 8-K | -0.25% | +2.65% | |
| Form ARS Denali Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | -0.52% | +4.45% | |
| Form DEF 14A Denali Therapeutics Inc. For: Dec 31 | SEC filing · Form DEF | -0.52% | +4.45% | |
| Form DEFA14A Denali Therapeutics Inc. | SEC filing · Form DEFA14A | -0.52% | +4.45% | |
| Form 8-K Denali Therapeutics Inc. For: Apr 02 | SEC filing · Form 8-K | +2.44% | +13.84% | |
| Form 8-K Denali Therapeutics Inc. For: Mar 05 | SEC filing · Form 8-K | -1.22% | +4.23% | |
| Form 10-K Denali Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -3.98% | -12.05% | |
| Form 8-K Denali Therapeutics Inc. For: Feb 27 | SEC filing · Form 8-K | -3.98% | -12.05% | |
| Form S-3ASR Denali Therapeutics Inc. | SEC filing · Form S-3ASR | -3.98% | -12.05% | |
| Form S-8 Denali Therapeutics Inc. | SEC filing · Form S-8 | -3.98% | -12.05% | |
| Form 8-K Denali Therapeutics Inc. For: Jan 13 | SEC filing · Form 8-K | +1.31% | +3.05% | |
| Form 8-K Denali Therapeutics Inc. For: Jan 06 | SEC filing · Form 8-K | +7.18% | +12.66% | |
| Form 8-K Denali Therapeutics Inc. For: Nov 12 | SEC filing · Form 8-K | -0.48% | +1.71% | |
| Form 10-Q Denali Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.77% | +1.20% | |
| Form 8-K Denali Therapeutics Inc. For: Nov 06 | SEC filing · Form 8-K | +2.77% | +1.20% | |
| Form 8-K Denali Therapeutics Inc. For: Oct 10 | SEC filing · Form 8-K | +0.51% | +9.42% | |
| Form 10-Q Denali Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.51% | -1.98% | |
| Form 8-K Denali Therapeutics Inc. For: Aug 01 | SEC filing · Form 8-K | +1.51% | -1.98% | |
| Form 8-K Denali Therapeutics Inc. For: May 31 | SEC filing · Form 8-K | +2.54% | +7.77% | |
| Form 10-Q Denali Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +4.62% | +11.18% | |
| Form 8-K Denali Therapeutics Inc. For: May 07 | SEC filing · Form 8-K | +4.62% | +11.18% | |
| Form ARS Denali Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | +1.30% | -3.03% | |
| Form DEF 14A Denali Therapeutics Inc. For: Dec 31 | SEC filing · Form DEF | +1.30% | -3.03% | |
| Form DEFA14A Denali Therapeutics Inc. | SEC filing · Form DEFA14A | +1.30% | -3.03% | |
| Form S-3ASR Denali Therapeutics Inc. | SEC filing · Form S-3ASR | +2.53% | +2.58% | |
| Form D Denali Therapeutics Inc. | SEC filing · Form D | -2.03% | -3.50% | |
| Form 10-K Denali Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -3.06% | -10.22% | |
| Form S-8 Denali Therapeutics Inc. | SEC filing · Form S-8 | -3.06% | -10.22% | |
| Form 8-K Denali Therapeutics Inc. For: Feb 27 | SEC filing · Form 8-K | -2.01% | +17.10% | |
| Form 8-K Denali Therapeutics Inc. For: Feb 16 | SEC filing · Form 8-K | -4.36% | -4.27% | |
| Form 8-K Denali Therapeutics Inc. For: Jan 08 | SEC filing · Form 8-K | -1.18% | +5.71% | |
| Form 10-Q Denali Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.69% | +0.70% | |
| Form 8-K Denali Therapeutics Inc. For: Nov 07 | SEC filing · Form 8-K | -2.69% | +0.70% | |
| Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines | Press release | -0.13% | -1.05% |
Keep exploring
More DNLI: earnings → · analyst actions → · DNLI overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Senseonics Holdings, Inc. (SENS) | 318 | -0.44% | 42% |
| Allogene Therapeutics, Inc. (ALLO) | 316 | +0.18% | 51% |
| Myomo Inc. (MYO) | 315 | +0.35% | 54% |
| ICU Medical, Inc. (ICUI) | 313 | +0.02% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.